Published in JAMA, the study reviewed data from 943,456 individuals with type 1 diabetes (2010-2023) through the Epic Cosmos database, finding that while these drugs were used off-label, clinicians were often motivated by the need to manage obesity and cardiovascular or renal complications in type 1 diabetes
1166,1167 Despite significant efforts, there are currently no approved treatments specifically targeting cardiac metabolism
Pharmaceutical companies Novo Nordisk, Eli Lilly, and others are continually creating and testing new medications that might work better, have fewer side effects, or last longer
Femi-Adepoju, A
Peroxynitrite induces apoptosis in a number of cell types in culture, including pheochromocytoma derived PC12 cells, cortical neurons, HL-60 cells and rat thymocytes [22]
it's about understanding which method aligns best with your specific research goals and constraints in 2026